Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells.
about
Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNSRational modulation of the innate immune system for neuroprotection in ischemic strokeTherapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cellsRegulation of LRRK2 expression points to a functional role in human monocyte maturationIn vivo dynamics of innate immune sentinels in the CNS.Activation of immune responses to brain antigens after stroke.Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?Microglial phenotype and adaptation.Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAEAbsence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in miceFlt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain.CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progressionSilencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDSViral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb.The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells.Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1.Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particlesCopper modulates the phenotypic response of activated BV2 microglia through the release of nitric oxide.Immune cell trafficking from the brain maintains CNS immune tolerance.Brain dendritic cells: biology and pathology.Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.Advancing drug delivery systems for the treatment of multiple sclerosis.Antigen Presentation After Stroke.Inflammation and Stroke: An OverviewEfficiently stimulated adult microglia cross-prime naive CD8+ T cells injected in the brain.Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy.Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments.A case of mistaken identity: CD11c-eYFP(+) cells in the normal mouse brain parenchyma and neural retina display the phenotype of microglia, not dendritic cells.Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses Against Herpes Infection and Disease‡.Neuroinflammation: Microglia and T Cells Get Ready to Tango.Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model.Targeting DEC-205−DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.
P2860
Q26772718-B57A30C7-6F9F-490A-9D37-3CA4BECB2D1CQ26851831-5B305267-1749-432B-8F84-BC0DE4C1C8F9Q27308832-82F9ECA5-122C-468C-A5CE-4948BF39D101Q28743193-A1DF4BBB-95D8-40EF-BFFA-75D62DAA5E22Q30547038-B6909BAB-152A-4AED-AFB5-44DC22766A5DQ34069139-E4F22F61-EAFA-4627-BF28-D7FFFBDE2A2CQ34219556-B1A96868-67DB-4D43-8B96-05FF85B78B49Q34359569-E5C48965-8BC4-4F3C-BED6-CBD93044B63DQ34602629-8067DC2F-D2B2-487C-867E-137E1397E068Q35094493-9C997B42-C18C-430D-82ED-B83AF8C27A86Q35144558-D859D789-A51A-4E26-8C63-8AC26FE255BBQ35185219-95F470B9-72A6-43A9-B1FC-4D0C16BC5310Q35472172-4F7BA936-73DA-472C-908C-BCEF4CBBF8EEQ35784621-1F256EBD-4323-4A24-A000-A922B960DA1BQ35924747-FDD148D8-20D8-49DC-802A-D5B50C0AE172Q36005107-C47FEE75-F2FB-4C26-A2DE-171C223106D3Q36143936-6C13E5FC-BD16-49F6-9AA1-B0B0B8E3ACF5Q36513937-D8D7FF54-0913-4582-957D-45ACF4CAFBAEQ36945745-1A9546E5-32C0-432F-8934-B48903AC26A8Q37064144-E5186876-7EAD-40EF-BA3E-78F1EA60F758Q37602206-679E0B80-8310-45DE-9F47-511F412EBF9EQ38028845-6D93637D-AABC-40DA-9473-B7CE047E4BB9Q38079579-225B297C-33C2-4995-8FF3-21BB2B6B0693Q38227496-7E67F63F-37A3-4F04-856F-0143ED59E2D7Q38609620-4CFF0D56-14D0-4D7A-8C30-718AED25298AQ38925065-B2B20802-C0AC-4DFD-BB9F-D4AD5DFF4F79Q38978527-A4D6715B-1DC7-448E-9A2C-F076901C3E86Q45990565-EA24C029-3BCA-4730-8CA3-4E47427286C6Q47222390-5737FD38-DFC7-430C-B584-04464845E618Q47372399-B18A32CF-A64E-42C7-990A-5F0FFB671B04Q48424710-574F09A4-186D-4AA4-B727-E6DB48F8AC9BQ48729243-ECEE13F9-8E7E-48F1-A073-F4E2487EB023Q50043299-A2228C83-9BC9-422D-9F86-7FE29A0F337EQ50106151-60C5CF0B-51A9-4328-B87F-B3DD7A6722B4Q52639396-77CBBC7B-7093-4AF3-980E-D3B3FE39BC35Q55502642-7F08DE3E-17D1-4319-BC79-FD04412851CC
P2860
Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@en
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@nl
type
label
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@en
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@nl
prefLabel
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@en
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@nl
P2093
P2860
P356
P1476
Acute in vivo exposure to inte ...... tive antigen presenting cells.
@en
P2093
Andres Gottfried-Blackmore
Bruce S McEwen
Jennifer C Felger
Juliana Idoyaga
Karen Bulloch
Ulrike W Kaunzner
P2860
P304
20918-20923
P356
10.1073/PNAS.0911509106
P407
P577
2009-11-11T00:00:00Z